EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Adverse Effects of Immune-Checkpoint Inhibitors: A Comprehensive Imaging-Oriented Review

Carlo Augusto Mallio iD, Caterina Bernetti, Laura Cea, Andrea Buoso iD, Massimo Stiffi, Daniele Vertulli iD, Federico Greco iD, Bruno Beomonte Zobel

Current Oncology · 03.05.2023 · 30 (5) · 4700-4723

DOI: 10.3390/curroncol30050355 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 03.05.2023. Verfasst von Carlo Augusto Mallio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune-checkpoint inhibitors (ICIs) are immunomodulatory monoclonal antibodies, which increase antitumor immunity of the host and facilitate T-cell-mediated actions against tumors. These medications have been used in recent years as a weapon against advanced stage malignancies, such as melanoma, renal cell carcinoma, lymphoma, small or non-small cell lung cancer, and colorectal cancer. Unfortunately, they are not free from possible adverse effects (immune-related adverse events—irAEs) that mainly affect skin, gastrointestinal, hepatic, and endocrine systems. Early diagnosis of irAEs is essential to correctly and rapidly manage patients, with ICIs suspension and therapies administration. Deep knowledge of the imaging and clinical patterns of irAEs is the key to promptly rule out other diagnoses. Here, we performed a review of the radiological signs and differential diagnosis, based on the organ involved. The aim of this review is to provide guidance to recognize the most significant radiological findings of the main irAEs, based on incidence, severity, and the role of imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMelanomaDrug-Related Side Effects and Adverse ReactionsHumansImmune Checkpoint InhibitorsAntibodies, Monoclonal

Stichwörter der Autor:innen

adverse effectscancerimagingimmune-checkpoint inhibitorsimmunotherapy

Substanzen

Immune Checkpoint InhibitorsAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Medicine and Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy.
  • Department of Medicine and Surgery, Research Unit of Radiology, Università Campus Bio-Medico di Roma, 00128 Roma, Italy.
  • Unità Operativa Complessa Diagnostica per Immagini Territoriale Aziendale, Cittadella della Salute Azienda Sanitaria Locale di Lecce, Piazza Filippo Bottazzi, 73100 Lecce, Italy.

ORCID-Profile: Carlo Augusto Mallio, Andrea Buoso, Daniele Vertulli, Federico Greco

Zitieren

APA

Mallio, C. A., Bernetti, C., Cea, L., Buoso, A., Stiffi, M., Vertulli, D., Greco, F., & Zobel, B. B. (2023). Adverse Effects of Immune-Checkpoint Inhibitors: A Comprehensive Imaging-Oriented Review. Current Oncology, 30(5), 4700-4723. https://doi.org/10.3390/curroncol30050355

Vancouver

Mallio CA, Bernetti C, Cea L, Buoso A, Stiffi M, Vertulli D, et al. Adverse Effects of Immune-Checkpoint Inhibitors: A Comprehensive Imaging-Oriented Review. Current Oncology. 2023;30(5):4700-4723. doi:10.3390/curroncol30050355

BibTeX
@article{Mallio2023,
  author = {Mallio, Carlo Augusto and Bernetti, Caterina and Cea, Laura and Buoso, Andrea and Stiffi, Massimo and Vertulli, Daniele and Greco, Federico and Zobel, Bruno Beomonte},
  title = {Adverse Effects of Immune-Checkpoint Inhibitors: A Comprehensive Imaging-Oriented Review},
  journal = {Current Oncology},
  year = {2023},
  volume = {30},
  number = {5},
  pages = {4700--4723},
  doi = {10.3390/curroncol30050355}
}
Kostenlos starten →